Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-01-26 Purchase | 2022-01-26 4:13 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 100,000 | $0.2152 | $21,520 | 2,017,006 (Direct) | View |
| 2022-01-03 Sale | 2022-01-04 4:17 pm | Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director | 40,000 | $22.59 | $903,650 | 13,500 (Direct) | View |
| 2021-05-17 Sale | 2021-05-17 7:13 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 4,186 | $0.89 | $3,726 | 316,292 (Direct) | View |
| 2021-02-16 Sale(A) | 2021-04-16 4:11 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 4,144 | $1.72 | $7,128 | 244,628 (Direct) | View |
| 2021-02-16 Sale | 2021-02-17 5:23 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 4,144 | $1.72 | $7,128 | 485,756 (Direct) | View |
| 2020-11-16 Sale | 2020-11-18 4:09 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 6,094 | $0.5211 | $3,176 | 215,994 (Direct) | View |
| 2020-08-14 Sale | 2020-08-17 8:22 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 4,245 | $0.6049 | $2,568 | 222,088 (Direct) | View |
| 2020-05-15 Sale | 2020-05-18 4:28 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 4,426 | $0.6267 | $2,774 | 226,333 (Direct) | View |
| 2020-02-18 Sale | 2020-02-19 6:09 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 4,324 | $0.8304 | $3,591 | 230,759 (Direct) | View |
| 2020-01-02 Sale | 2020-01-03 4:07 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 8,345 | $0.9667 | $8,067 | 235,083 (Direct) | View |
| 2019-11-14 Sale | 2019-11-15 5:36 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 5,838 | $0.64 | $3,736 | 243,428 (Direct) | View |
| 2019-10-01 Sale | 2019-10-02 6:17 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 8,743 | $0.6827 | $5,969 | 249,266 (Direct) | View |
| 2019-08-15 Sale | 2019-08-16 4:17 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 4,375 | $0.5506 | $2,409 | 258,009 (Direct) | View |
| 2019-07-01 Sale | 2019-07-02 5:42 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 5,783 | $1.3115 | $7,584 | 262,384 (Direct) | View |
| 2019-05-16 Sale | 2019-05-16 5:25 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 39,352 | $1.2189 | $47,966 | 278,167 (Direct) | View |
| 2019-05-07 Purchase | 2019-05-08 5:15 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 33,194 | $1.08 | $35,850 | 97,736 (Direct) | View |
| 2019-04-01 Sale | 2019-04-03 4:31 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 5,842 | $0.981 | $5,731 | 31,348 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-11 Option Award | 2023-01-17 4:11 pm | N/A 2033-01-10 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-05-18 Option Award | 2022-05-20 4:07 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director | 23,345 | $0 | 23,345 (Direct) | View |
| 2022-05-10 Option Award | 2022-05-11 4:54 pm | N/A 2030-01-20 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-26 4:13 pm | N/A 2032-01-11 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 1,600,000 | $0 | 2,017,006 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-04 4:17 pm | N/A 2028-02-08 | Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director | 40,000 | $0 | 13,500 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-04 4:17 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director | 40,000 | $5.08 | 13,500 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-16 9:23 pm | N/A 2031-06-14 | Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director | 31,347 | $0 | 31,347 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 8:31 pm | N/A 2031-06-09 | Zosano Pharma Corp | ZSAN | Hagan Joseph P Director | 45,000 | $0 | 52,500 (Direct) | View |
| 2021-04-14 Conversion | 2021-04-16 4:12 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 83,435 | $0 | 320,478 (Indirect) | View |
| 2021-02-04 Option Award | 2021-02-05 5:01 pm | N/A 2031-02-04 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 600,000 | $0 | 600,000 (Direct) | View |
Ownership | 2021-01-04 5:56 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director | 0 | $0 | 128,500 (Direct) | View |
| 2020-12-04 Option Award | 2020-12-07 4:22 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 39,680 | $0.6301 | 255,434 (Indirect) | View |
| 2020-12-04 Option Award | 2020-12-07 4:22 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 29,760 | $0.125 | 255,434 (Indirect) | View |
| 2020-06-25 Option Award | 2020-06-29 9:54 pm | N/A N/A | Zosano Pharma Corp | ZSAN | Hagan Joseph P Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 5:05 pm | N/A 2030-06-02 | Zosano Pharma Corp | ZSAN | Hagan Joseph P Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-01-22 Option Award | 2020-01-24 4:13 pm | N/A 2030-01-21 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 900,000 | $0 | 900,000 (Direct) | View |
| 2019-12-24 Option Award | 2019-12-26 08:50 am | 2019-12-24 2024-12-24 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 75,850 | $0.125 | 83,435 (Indirect) | View |
| 2019-12-24 Option Award | 2019-12-26 08:50 am | N/A N/A | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 7,585 | $6.66 | 83,435 (Indirect) | View |
| 2019-10-10 Option Award | 2019-10-15 4:43 pm | N/A 2029-10-09 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 1,000,000 | $0 | 1,000,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-07-18 4:08 pm | N/A 2029-01-02 | Zosano Pharma Corp | ZSAN | Hagan Joseph P Director | 1,500 | $0 | 1,500 (Direct) | View |
| 2019-05-07 Option Award(A) | 2019-05-21 4:42 pm | 2019-05-07 2024-05-07 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 33,194 | $0.125 | 97,736 (Direct) | View |
| 2019-05-07 Option Award(A) | 2019-05-21 4:42 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 33,194 | $1.08 | 97,736 (Direct) | View |
| 2019-05-14 Option Award | 2019-05-16 5:25 pm | 2019-05-14 2029-02-04 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 198,385 | $0 | 278,167 (Direct) | View |
| 2019-02-05 Option Award | 2019-02-06 4:51 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 65,000 | $0.95 | 149,148 (Direct) | View |
| 2019-02-05 Option Award | 2019-02-06 4:51 pm | N/A 2029-02-04 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 65,000 | $0 | 149,148 (Direct) | View |
| 2018-05-31 Option Award | 2018-06-01 7:06 pm | N/A 2028-04-16 | Zosano Pharma Corp | ZSAN | Hagan Joseph P Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2018-05-17 Option Award | 2018-05-21 4:40 pm | N/A 2028-05-16 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO | 725,000 | $0 | 725,000 (Direct) | View |